The RANGER II superficial femoral artery trial: 1-year results of the long lesion cohort

BACKGROUND: The objective of the RANGER II SFA long lesion cohort analysis was to evaluate the safety and effectiveness of the Ranger drug-coated balloon (DCB) in patients with lesion lengths greater than 100 mm. METHODS: Patients from the RANGER II SFA randomized controlled trial and long balloon s...

Descripción completa

Detalles Bibliográficos
Autores principales: Schroë, Herman, Sachar, Ravish, Keirse, Koen, Soga, Yoshimitsu, Brodmann, Marianne, Rao, Vikram, Werner, Martin, Holden, Andrew, Lopez, Louis, Krishnan, Prakash, Diaz-Cartelle, Juan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9551318/
https://www.ncbi.nlm.nih.gov/pubmed/35943120
http://dx.doi.org/10.1177/1358863X221097164

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9551318/
https://www.ncbi.nlm.nih.gov/pubmed/35943120
http://dx.doi.org/10.1177/1358863X221097164

Ejemplares similares